TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma

IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells

(2015) C. Schinke et al.   BLOOD

CXCL5 Promotes Prostate Cancer Progression

(2015) Lesa A Begley et al.   NEOPLASIA

Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis

(2014) Yanchun Li et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas

(2014) Shuji Mikami et al.   INTERNATIONAL JOURNAL OF CANCER

The roles of mesenchymal stem cells in tumor inflammatory microenvironment

(2014) Zhao Sun et al.   Journal of Hematology & Oncology

Galectin-1 Upregulates CXCR4 to Promote Tumor Progression and Poor Outcome in Kidney Cancer

(2014) C.-S. Huang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Association of CXCR3 and Renal Cell Carcinoma Metastasis

(2014) Takanobu Utsumi et al.   JOURNAL OF UROLOGY

Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment

(2014) Naofumi Mukaida et al.   MEDIATORS OF INFLAMMATION

The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma

(2013) R. Grepin et al.   CANCER RESEARCH

Microenvironmental regulation of tumor progression and metastasis

(2013) Daniela F Quail et al.   NATURE MEDICINE

SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis

(2013) Raul Aguirre-Gamboa et al.   PLoS One

Emerging immunotherapies for renal cell carcinoma

(2012) B. Escudier   ANNALS OF ONCOLOGY

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Cellular Constituents of Immune Escape within the Tumor Microenvironment

(2012) S. P. Kerkar et al.   CANCER RESEARCH

TNF-  Induces Epithelial-Mesenchymal Transition of Renal Cell Carcinoma Cells via a GSK3 -Dependent Mechanism

(2012) M.-Y. Ho et al.   MOLECULAR CANCER RESEARCH

Tumor necrosis factor-α induces epithelial–mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism

(2011) Sheng-Tang Wu et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas

(2010) Blanche Ka Ki Lo et al.   AMERICAN JOURNAL OF PATHOLOGY

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

(2010) Christophe Ginestier et al.   JOURNAL OF CLINICAL INVESTIGATION

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model

(2009) X. Ma et al.   MOLECULAR CANCER THERAPEUTICS

Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells

(2008) Mei-Jen Chuang et al.   CANCER SCIENCE

Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence

(2008) Juan C. Acosta et al.   CELL

TNF: A master switch for inflammation to cancer

(2008) Gautam Sethi   Frontiers in Bioscience-Landmark

Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor- B Transcription and Evasion of Apoptosis

(2008) C. Wilson et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Calcineurin Inhibitors Modulate CXCR3 Splice Variant Expression and Mediate Renal Cancer Progression

(2008) D. Datta et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Chemokine Receptor CXCR3 is an Independent Prognostic Factor in Patients With Localized Clear Cell Renal Cell Carcinoma

(2007) Tobias Klatte et al.   JOURNAL OF UROLOGY